<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>PEPTIDE REACH Insights</title>
    <link>https://peptidereach.com/insights/</link>
    <description>Peptide market, product and B2B supply insights for professional buyers.</description>
    <language>en</language>
    <atom:link href="https://peptidereach.com/rss.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>BPC-157 vs TB-500: Pathways, Market Positioning and Product Differences</title>
      <link>https://peptidereach.com/insights/bpc-157-vs-tb-500/</link>
      <guid isPermaLink="true">https://peptidereach.com/insights/bpc-157-vs-tb-500/</guid>
      <pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
      <description>A B2B comparison of BPC-157 and TB-500 for recovery and performance markets, covering pathway differences and commercial positioning.
</description>
    </item>
<item>
      <title>GHK-Cu in Skin and Hair Markets: Why the Copper Peptide Stands Out</title>
      <link>https://peptidereach.com/insights/ghk-cu-skin-hair-market/</link>
      <guid isPermaLink="true">https://peptidereach.com/insights/ghk-cu-skin-hair-market/</guid>
      <pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
      <description>A B2B look at GHK-Cu, its cosmetic-market relevance, and how brands and formulators can evaluate it for private-label programmes.
</description>
    </item>
<item>
      <title>A B2B Guide to Growth-Hormone Pathway Peptides</title>
      <link>https://peptidereach.com/insights/growth-hormone-releasing-peptides-guide/</link>
      <guid isPermaLink="true">https://peptidereach.com/insights/growth-hormone-releasing-peptides-guide/</guid>
      <pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
      <description>A professional guide to Tesamorelin, Ipamorelin, and CJC-1295 (No DAC) for buyers evaluating growth-hormone pathway peptides.
</description>
    </item>
<item>
      <title>COA, HPLC and LC-MS: A Practical Peptide Document Guide</title>
      <link>https://peptidereach.com/insights/peptide-coa-hplc-lcms-explained/</link>
      <guid isPermaLink="true">https://peptidereach.com/insights/peptide-coa-hplc-lcms-explained/</guid>
      <pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
      <description>A plain-language guide to the most commonly requested peptide quality documents and what each one tells a professional buyer.
</description>
    </item>
<item>
      <title>What B2B Buyers Should Ask a Peptide Supplier</title>
      <link>https://peptidereach.com/insights/peptide-wholesale-buyer-checklist/</link>
      <guid isPermaLink="true">https://peptidereach.com/insights/peptide-wholesale-buyer-checklist/</guid>
      <pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
      <description>A practical checklist for distributors, clinics, and brands evaluating a peptide supplier for wholesale, OEM, or private-label partnerships.
</description>
    </item>
<item>
      <title>Retatrutide: Triple-Agonist Mechanism and Market Overview</title>
      <link>https://peptidereach.com/insights/retatrutide-mechanism-market-overview/</link>
      <guid isPermaLink="true">https://peptidereach.com/insights/retatrutide-mechanism-market-overview/</guid>
      <pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
      <description>A B2B overview of Retatrutide&apos;s triple-agonist mechanism, its position in the incretin market, and what wholesale buyers should know.
</description>
    </item>
  </channel>
</rss>